MELK mediates the stability of EZH2 through site-specific phosphorylation in extranodal natural killer/T-cell lymphoma
Journal article published in 2019 by
Boheng Li,
Junli Yan,
The Phyu,
Shuangyi Fan,
Tae-Hoon Chung,
Nurulhuda Mustafa,
Baohong Lin,
Lingzhi Wang 
,
Pieter Johan Adam Eichhorn ,
Boon-Cher Goh,
Siok-Bian Ng,
Dennis Kappei ,
Wee-Joo Chng
,
Pieter Johan Adam Eichhorn ,
Boon-Cher Goh,
Siok-Bian Ng,
Dennis Kappei ,
Wee-Joo Chng
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
This article describes the interplay between the serine/threonine kinase maternal embryonic leucine zipper kinase (MELK) and the enhancer of zeste 2 polycomb repressive complex 2 subunit (EZH2) and provides a basis for targeting this enzymatic pathway in mature natural killer/T-cell malignancies.